The Global Bovine Colostrum Market was evaluated at US$408.382 million for the year 2020, growing at a CAGR of 3.39%, reaching the market size of US$515.742 million by the year 2027.
The bovine colostrum market is expected to grow significantly in the coming years. It is a milk-based fluid from the cow's breasts for a few days after the cow gives birth. The milk is temporary and should be used within a few days. After that, true cow’s milk appears. Milk contains a lot of proteins, fats, carbohydrates, and minerals. It also contains a variety of antibodies and prevents viruses and bacteria in the body. Bovine milk has many ends uses. The antibodies' properties in bovine milk are greater than in regular milk.
Because of that, bovine milk is consumed by athletes to build muscles, burn fat, enhance stamina and agility, and make a considerable improvement in overall performance. It also has many health benefits and is used by many people. The major companies are investing a considerable sum of capital into research and development, innovation, and enhancing the quality of milk-based products. Governments worldwide have also started various R & D programs and are collaborating with the local and major companies to enhance and improve the quality of the product. With the varying consumer preferences and the surge in consumers' awareness of the use of healthier products, the B bovine C colostrum milk industry is expected to grow significantly in the coming years.
Enhancing Immunity and Offering Healthier Properties
Consumers have become aware of the product's properties and applications. There has also been a significant change in consumer behaviour and preference for a product. The bovine colostrum market will continue to grow significantly as the consumers learn about the immune-boosting immunity booster properties of the milk and its more imperative health benefits. It reduces the symptoms of upper respiratory way infections in those who are fitness enthusiasts. It also reduces critically infectious diarrhea in people, especially HIV/AIDS diseases. It is also beneficial for people and children with weaker immunity. It also prevents the flu and helps those who have heart diseases. The companies related to this segmentation invest a lot in these applications to enhance their portfolio and satisfy the consumer. There are huge opportunities for companies in infant segmentation. Bovine C colostrum provides proteins and enhances immunity in infants and babies. There has been widespread research and studies related to human and bovine colostrum milk properties. Human colostrum is needed for infant growth as it contains a considerable lactose concentration. But, sometimes, there is a need to support physiological growth in infants, which cannot be completely fulfilled by the human colostrum. Therefore, bovine colostrum is needed for that. Thus, the market will continue to register significant growth as there are many properties in this milk product.
COVID-19 has had an impact on economies and industries in the various region due to foisted lockdowns, travel restrictions, and business closures. As a result of the pandemic, F&B sector which is one of the key sector was experiencing severe disruptions such as service failures, dysregulated manufacturing, and office closures. As a result, lack of exercise, bad quality food, and close-quarters between animals to avoid frequently result in illness among these animals, cows are raised in harsh circumstances because of stringent regulations and kept in extremely constrained quarters day and night. They do not get enough workouts to stay healthy. It might reduce the quality of colostrum accumulated from cows over the forecasted period. These factors have also had an impact on the market for bovine colostrum globally.
The economic suffer damage as a result of a lack of income from various industries.
By nature, the conventional segment has a major share in the market. This is because the milk is treated before being consumed to make it safer for human consumption. Cows are vaccinated before so they can develop antibodies that are collected in the colostrum milk. The organic segment will also have decent growth in the coming years.
By type, tablets and powder have a major share in the market and are expected to hold a significant share in the coming years. This is because powder blends easily with any beverage product, and the tablets are consumed by athletes and people with certain significant conditions. Liquid and capsules will also show register decent growth. With the surge in scientific research and R & D, the liquid segment will have a considerable share in the market.
By A applications, available food types hold a significant share in the market. It is easier to blend bovine colostrum with functional foods, and it registers a significant demand in the market. Pharmaceuticals and sports nutrition will also have considerable growth as the colostrum is registering a substantial demand among athletes and fitness enthusiasts.
By D distribution C channel, the retail segment holds a significant market share. Hypermarkets, Supermarkets, and convenience stores hold a significant share. Drug stores are also expected to register considerable growth in the coming years because of the surge in product surging applications in the pharmaceutical sector. Online retail will also register decent growth as the manufacturers connect directly with the consumers. Many companies are selling their products through E e-Commerce websites.
There has been a surge in demand for bovine colostrum in sports nutrition-based products as they have many healthier properties, such as preventing intestinal injury and upper respiratory problems. It also boosts athletes' immunity during intense workouts and reduces stress among individuals. It also enhances the immunity of athletes during an intense workout and reduces stress in an individual. It is also used as a supplement, and the major companies are investing in protein supplements to enhance their portfolio and make a significant impact in the market.
There has been a surge in demand for bovine colostrum in developing countries, especially in the infant formula segment. The milk is safer to use and is a more digestible product. It also prevents pathogens in an infant's stomach and contains a substantial amount of immunoglobulin.
The Asia- Pacific region holds a significant share of the market and is expected to register considerable growth. Due to the availability of major companies and the wider dairy industry, North America will also hold a significant market share. North America will also hold a significant market share due to the availability of major companies and the wider dairy industry. Many US B biotechnology companies have invested millions of dollars and are collaborating with various dairy companies. Asian C companies are also investing substantial resources in colostrum milk products. Europe is also expected to register decent growth.
Some of the major companies in the market are APS Biogroup, Genceutic Naturals, Agati Healthcare Pvt. Ltd., NOW Health Group Inc., Biostrum Nutritech Pvt. Ltd., PuraLife LLC., Farbest Brands, Jarrow Formulas Inc., Vivesa Holding s.r.o., and iodane Pharma A/S. There has been a significant share of local dairy companies in the market. Governments worldwide provide incentives in R & D to companies that indulge in scientific research and development of bovine colostrum products. U.S. Food and Drug Administration has given special status to the bovine colostrum product, which permits the sale of the product in the market for 7 years without competition.
Strategies and Launches
PanTheryx, the largest colostrum-based biotechnology and nutrition company, revealed that it has completed the acquisition of the Goodgut digestive health brand name, which includes the Preliva polyphenol prebiotic formula. Preliva, a plant-based item from Goodgut, is intended to help the good bacteria in the gut thrive, which endorses the immune system of the body and encourages digestive health. This acquisition adds a high-quality prebiotic to PanTheryx's product offerings, which already include bovine colostrum for immune and digestive wellbeing.
Experts in bovine genetics Cogent has launched Primestart Colostrum, which is a water-soluble, heavily guarded colostrum product designed to provide newborn calves with a natural, elevated feed at birth.
Tallink Grupp's Estonian notified vessels are going to offer BioBlock, an innovative nasal spray derived from bovine colostrum have antibodies to fight Covid-19. Tallink Grupp is thrilled that production levels of the novel prophylaxis nasal spray comprising antibodies against SARS-CoV-2, developed and manufactured in Estonia, have increased.
PanTheryx, a holistic digestive and immune health organisation unveiled ColostrumOne, its new bovine (cow) colostrum preparation. The new innovative product has been clinically proven to safeguard Immunoglobulin G (IgG), innate immunity and growth variables as they enter the digestive system.
|Market size value in 2020||US$408.382 million|
|Market size value in 2027||US$515.742 million|
|Growth Rate||CAGR of 3.39% from 2020 to 2027|
|Forecast Unit (Value)||USD Million|
|Segments covered||Nature, Form, Application, Distribution Channel, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||APS Biogroup, Genceutic Naturals, Agati Healthcare Pvt Ltd., NOW Health Group Inc., Biostrum Nutritech Pvt. Ltd., PuraLife LLC., Farbest Brands, Jarrow Formulas Inc., Biodane Pharma A/S|
|Customization scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Q1. What will be the bovine colostrum market size by 2027?
A1. The global bovine colostrum market is expected to reach a total market size of US$515.742 million by 2027.
Q2. What is the size of the global bovine colostrum market?
A2. Bovine Colostrum Market was valued at US$408.382 million in 2020.
Q3. What are the growth prospects for the bovine colostrum market?
A3. The bovine colostrum market is expected to grow at a CAGR of 3.39% during the forecast period.
Q4. What factors are anticipated to drive the bovine colostrum market growth?
A4. With the varying consumer preferences and the surge in the awareness to use healthier products, the Bovine Colostrum milk industry is expected to grow at a significant rate in the coming years.
Q5. Which region holds the largest market share in the bovine colostrum market?
A5. The Asia Pacific holds a significant share in the bovine colostrum market and is expected to register considerable growth.
Agati Healthcare Pvt Ltd.
NOW Health Group Inc.
Biostrum Nutritech Pvt. Ltd.
Jarrow Formulas Inc.
Biodane Pharma A/S
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.